Results 31 to 40 of about 41,523 (233)

Imaging Atherosclerosis With F18-Fluorodeoxyglucose Positron Emission Tomography

open access: bronzeJournal of the American College of Cardiology, 2011
Coronary heart disease remains the leading cause of death in the U.S. Despite advances in diagnostic imaging and therapy, identification of patients at risk remains challenging. Anatomical imaging of luminal narrowing and determination of plaque size alone have proven to be inadequate ([1][1 ...
Joseph C. Wu, Patricia K. Nguyen
openalex   +4 more sources

Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis [PDF]

open access: bronzeJournal of Nuclear Cardiology, 2014
Sarcoidosis is a disease of unknown etiology which is characterized by the formation of non-caseating granulomas in multiple organs. Cardiac involvement in sarcoidosis, which occurs in at least one in four patients, is associated with a worse prognosis and significant morbidity from conduction abnormalities, arrhythmias, and congestive heart failure ...
Alfonso H. Waller, Ron Blankstein
openalex   +5 more sources

Role of F18 fluorodeoxyglucose positron-emission tomography/computed tomography in the management of Askin′s tumor

open access: greenIndian Journal of Nuclear Medicine, 2013
A primitive neuroectodermal tumor (PNET) of the thoraco-abdominal region is one of a group of small round cell tumors usually found in children and young adults, originally described by Askin et al. Most cases arise in the soft-tissues of the thorax, but may rarely occur within the lung with the symptoms of chest wall pain, pleural effusion and dyspnea.
Anish Bhattacharya   +4 more
openalex   +5 more sources

Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign [PDF]

open access: bronzeCancer, 2009
AbstractBACKGROUND:Correct pretreatment classification is critical for optimizing diagnosis and treatment of patients with peripheral nerve sheath tumors (PNSTs). The aim of this study was to evaluate whether F18‐fluorodeoxyglucose positron emission tomography (FDG PET) can differentiate malignant (MPNST) from benign PNSTs.METHODS:Thirty‐four adult ...
Matthias Benz   +8 more
openalex   +6 more sources

F-18 fluorodeoxyglucose positron emission tomography/computed tomography in the infection of heart [PDF]

open access: yesYeungnam University Journal of Medicine, 2021
Infections involving the heart are becoming increasingly common, and a timely diagnosis of utmost importance, despite its challenges. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a recently introduced ...
Eunjung Kong
doaj   +1 more source

Metabolic Tumour Volume as a Predictor of Survival for Sinonasal Tract Squamous Cell Carcinoma

open access: yesDiagnostics, 2022
Background: High uptake of F18-fluorodeoxyglucose parameters for glucose metabolism is related to shorter survival in sinonasal tract cancer with various histological classifications.
Hidenori Suzuki   +8 more
doaj   +1 more source

The Extent of Perfusion–F18-Fluorodeoxyglucose Positron Emission Tomography Mismatch Determines Mortality in Medically Treated Patients With Chronic Ischemic Left Ventricular Dysfunction

open access: bronzeJournal of the American College of Cardiology, 2005
The purpose of this study was to assess the determinants of mortality in a large group of patients with ischemic cardiomyopathy who are treated medically and the impact of the extent of viable tissue on prognosis.Whether the presence of viability drives mortality in patients with ischemic cardiomyopathy who are treated medically and whether the extent ...
Alessandro Desideri   +7 more
openalex   +5 more sources

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

open access: bronzeBlood, 2009
AbstractF18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a powerful tool to investigate the role of tumor metabolic activity and its suppression by therapy for cancer survival. As part of Total Therapy 3 for newly diagnosed multiple myeloma, metastatic bone survey, magnetic resonance imaging, and FDG-PET scanning were evaluated in 239 ...
Twyla B. Bartel   +11 more
openalex   +5 more sources

Home - About - Disclaimer - Privacy